Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality
worldwide. It has been projected to move from the sixth to the third most common cause of …

The management of chronic obstructive pulmonary disease (COPD) has improved
significantly due to advances in therapeutic agents, but it has also become apparent that …

Comorbidities such as cardiac disease, diabetes mellitus, hypertension, osteoporosis, and
psychological disorders are commonly reported in patients with chronic obstructive …

The natural course of chronic obstructive pulmonary disease (COPD) is complicated by the
development of systemic consequences and co-morbidities. These may be major features in …

By 2020, chronic obstructive pulmonary disease (COPD) will be the third cause of mortality.
Extrapulmonary comorbidities influence the prognosis of patients with COPD. Tobacco …

Chronic obstructive pulmonary disease (COPD) is a multicomponent disease with
inflammation at its core, and a major cause of morbidity and mortality. It represents a …

Evidence suggests that systemic inflammation may be the link between COPD and
comorbidities, but this issue is still debated. Whatever the mechanism underlying …

Chronic obstructive pulmonary disease (COPD) is associated with pulmonary and systemic
inflammation. The latter is likely to contribute significantly to the pathobiology of numerous …

The classical definition of Chronic Obstructive Pulmonary Disease (COPD) as a lung
condition characterized by irreversible airway obstruction is outdated. The systemic …

Comorbidities impact a large proportion of patients with chronic obstructive pulmonary
disease (COPD), with over 80% of patients with COPD estimated to have at least one …